Cardiovascular Complications in a Patient with Marfan Syndrome and Mitral Valve Prolapse. Systematic literature review.
Keywords:
Marfan syndrome, Mitral valve prolapse, Mitral valve, Heart failure, Cardiovascular complicationsAbstract
Background: Marfan syndrome (MS) is a disorder that affects connective tissue and is associated with abnormalities of the musculoskeletal system. Among the complications that can be triggered by MS, cardiovascular anomalies that lead to unfavorable outcomes such as mitral valve prolapse (MVP) must be taken into account. MVP in patients with MS can trigger subsequent complications, such as mitral regurgitation and heart failure.
Objective: Identify the cardiovascular complications of a patient with Marfan syndrome and mitral valve prolapse. Materials and methods: Systematized search of the literature in Medline, through PubMed, using the guidelines of the PRISMA Declaration for the selection of published studies. Results: Based on the 17 publications obtained in the systematized literature search process, the cardiovascular complications described were mitral regurgitation, mitral valve dysfunction, mitral valve replacement, infective endocarditis, dilatation of cavities and large vessels, heart failure, aortic dissection, reduced life expectancy, death, among others. Conclusions: MVP in patients with MS is one of the most important cardiovascular anomalies that lead to various cardiovascular complications, the main ones being mitral regurgitation and heart failure. For this reason, it is essential to recognize this relationship in order to prevent their development in time.
Downloads
References
Dietz HC (Updated June 30, 2009). Marfan syndrome. In: GeneReviews at GeneTest: Medical Genetics Information Resource (database online). Copyright, University of Washington, Seattle. 1997-2011. Disponible en: http://www.genetests.org (Accessed on April 20, 2011).
Yuan SM, Jing H. Marfan’s syndrome: an overview. Sao Paulo Med J. 2010; 128(6):360-6. DOI: 10.1590/s1516-31802010000600009
Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010; 47(7):476-85. DOI: 10.1136/jmg.2009.072785
Tsipouras P, Del Mastro R, Sarfarazi M, Lee B, Vitale E, Child AH, Godfrey M, Devereux RB, Hewett D, Steinmann B et al. Genetic linkage of the Marfan syndrome, ectopia lentis, and congenital contractural arachnodactyly to the fibrillin genes on chromosomes 15 and 5. The International Marfan Syndrome Collaborative Study. N Engl J Med. 1992; 326(14):905-9. DOI: 10.1056/NEJM199204023261401
Putnam EA, Zhang H, Ramirez F, Milewicz DM. Fibrillin-2 (FBN2) mutations result in the Marfan-like disorder, congenital contractural arachnodactyly. Nat Genet. 1995; 11(4):456-8. DOI: 10.1038/ng1295-456
Callewaert BL, Loeys BL, Ficcadenti A, Vermeer S, Landgren M, Kroes HY et al. Comprehensive clinical and molecular assessment of 32 probands with congenital contractural arachnodactyly: report of 14 novel mutations and review of the literature. Hum Mutat. 2009; 30(3):334-41. DOI: 10.1002/humu.20854
Thacoor A. Mitral valve prolapse and Marfan syndrome. Congenit Heart Dis. 2017; 12(4):430-434. DOI: 10.1111/chd.12467
Attias D, Stheneur C, Roy C, Collod-Béroud G, Detaint D, Faivre L et al. Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders. Circulation. 2009; 120(25):2541-9. DOI: 10.1161/CIRCULATIONAHA.109.887042
Grewal J, Suri R, Mankad S, Tanaka A, Mahoney DW, Schaff HV, Miller FA, Enriquez-Sarano M. Mitral annular dynamics in myxomatous valve disease: new insights with real-time 3-dimensional echocardiography. Circulation. 2010; 121(12):1423-31. DOI: 10.1161/CIRCULATIONAHA.109.901181
Clavel MA, Mantovani F, Malouf J, et al. Fenotipos dinámicos de la valvulopatía mitral mixomatosa degenerativa: estudio ecocardiográfico tridimensional cuantitativo. Circ Cardiovascular Imaging 2015; 8.
Rosas-Munive E, Valenzuela-Flores AG, Valenzuela-Flores AA. Prolapso valvular mitral. Revisión de la literatura [Mitral valve prolapse. A review]. Cir Cir. 2004; 72(5):415-20. 12. Lucas RV Jr, Edwards JE. The floppy mitral valve. Curr Probl Cardiol. 1982; 7(4):1-48. DOI: 10.1016/0146-2806(82)90016-0
Cole WG, Chan D, Hickey AJ, Wilcken DE. Collagen composition of normal and myxomatous human mitral heart valves. Biochem J. 1984; 219(2):451-60. DOI: 10.1042/bj2190451
Adams DH, Carabello BA, Castillo J. Insuficiencia de la válvula mitral. En: Hurst’s The Heart, 13th ed, Fuster V, Walsh RA, Harrington RA (Eds), McGraw-Hill, Nueva York 2010.
Grau JB, Pirelli L, Yu PJ, Galloway AC, Ostrer H. The genetics of mitral valve prolapse. Clin Genet. 2007;72(4):288-95. DOI: 10.1111/j.1399-0004.2007.00865.x
Glesby MJ, Pyeritz RE. Asociación de prolapso de válvula mitral y anomalías sistémicas del tejido conectivo. Un continuo fenotípico. JAMA 1989; 262:523.
Nishimura RA, Otto CM, Bonow RO, et al. Directrices de la AHA/ACC de 2014 para el tratamiento de pacientes con cardiopatía valvular: un informe del Grupo de Trabajo sobre Directrices Prácticas del Colegio Americano de Cardiología/Asociación Americana del Corazón. J Am Coll Cardiol 2014; 63: e57.
Avierinos JF, Gersh BJ, Melton LJ 3rd, Bailey KR, Shub C, Nishimura RA, Tajik AJ, Enriquez-Sarano M. Natural history of asymptomatic mitral valve prolapse in the community. Circulation. 2002;106(11):1355-61. DOI: 10.1161/01.cir.0000028933.34260.09. PMID: 12221052.
Kim S, Kuroda T, Nishinaga M, et al. Relación entre la gravedad de la IM y el pronóstico del prolapso de la válvula mitral: estudio ecocardiográfico de seguimiento. Am Heart J 1996; 132:348.
Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, McGoon MD, Bailey KR, Frye RL. Echocardiographic prediction of left ventricular function after correction of mitral regurgitation: results and clinical implications. J Am Coll Cardiol. 1994; 24(6):1536-43. DOI: 10.1016/0735-1097(94)90151-1
Crawford MH, Souchek J, Oprian CA, Miller DC, Rahimtoola S, Giacomini JC, Sethi G, Hammermeister KE. Determinants of survival and left ventricular performance after mitral valve replacement. Department of Veterans Affairs Cooperative Study on Valvular Heart Disease. Circulation. 1990; 81(4):1173-81. DOI: 10.1161/01.cir.81.4.1173
Urrútia G, Bonfill X. Declaración PRISMA: una propuesta para mejorar la publicación de revisiones sistemáticas y metaanálisis. Med Clin (Barc). 2010; 135(11):507-11. DOI: 10.1016/j.medcli.2010.01.015
Rybczynski M, Treede H, Sheikhzadeh S, Groene EF, Bernhardt AM, Hillebrand M, Mir TS, Kühne K, Koschyk D, Robinson PN, Berger J, Reichenspurner H, Meinertz T, von Kodolitsch Y. Predictors of outcome of mitral valve prolapse in patients with the Marfan syndrome. Am J Cardiol. 2011; 107(2):268-74. DOI: 10.1016/j.amjcard.2010.08.070
Rybczynski M, Mir TS, Sheikhzadeh S, Bernhardt AM, Schad C, Treede H, Veldhoen S, Groene EF, Kühne K, Koschyk D, Robinson PN, Berger J, Reichenspurner H, Meinertz T, von Kodolitsch Y. Frequency and age-related course of mitral valve dysfunction in the Marfan syndrome. Am J Cardiol. 2010; 106(7):1048-53. DOI: 10.1016/j.amjcard.2010.05.038
Wilcken DE. Genes, gender and geometry and the prolapsing mitral valve. Aust N Z J Med. 1992; 22(5 Suppl):556-61. DOI: 10.1111/j.1445-5994.1992.tb00476.x
Espínola-Zavaleta N, Iqbal FM, Nanda NC, Enríquez-Rodríguez E, Amezcua-Guerra LM, Bojalil-Parra R, Reyes PA, Soto ME. Echocardiographic study of a Mestizo-Mexican population with Marfan syndrome. Echocardiography. 2010; 27(8):923-30. DOI: 10.1111/j.1540-8175.2010.01208.x
Petitalot JP, Chaix AF, Barraine R. Echocardiographic features of triple valve prolapse with incompetent foramen ovale in Marfan’s syndrome. Am Heart J. 1986; 111(1):187-9. DOI: 10.1016/0002-8703(86)90576-4
Marlow N, Gregg JE, Qureshi SA. Mitral valve disease in Marfan’s syndrome. Arch Dis Child. 1987; 62(9):960-2. DOI: 10.1136/adc.62.9.960
Jolley MA, Hammer PE, Ghelani SJ, Adar A, Sleeper LA, Lacro RV, Marx GR, Nathan M, Harrild DM. Three-Dimensional Mitral Valve Morphology in Children and Young Adults With Marfan Syndrome. J Am Soc Echocardiogr. 2018; 31(11):1168-1177.e1. DOI: 10.1016/j.echo.2018.06.009
van Karnebeek CD, Naeff MS, Mulder BJ, Hennekam RC, Offringa M. Natural history of cardiovascular manifestations in Marfan syndrome. Arch Dis Child. 2001; 84(2):129-37. DOI: 10.1136/adc.84.2.129
Pyeritz RE, Wappel MA. Mitral valve dysfunction in the Marfan syndrome. Clinical and echocardiographic study of prevalence and natural history. Am J Med. 1983; 74(5):797-807. DOI: 10.1016/0002-9343(83)91070-7
Sarr SA, Djibrilla S, Aw F, Bodian M, Babaka K, Ngaidé AA, Dioum M, Ba SA. Marfan syndrome and cardiovascular complications: results of a family investigation. BMC Cardiovasc Disord. 2017; 17(1):193. DOI: 10.1186/s12872-017-0629-8
Demers P, Liang D, Miller DC. Images in cardiovascular medicine. Simultaneous “Tirone David-V” valve-sparing aortic root replacement and radical mitral valve repair for the Marfan syndrome with Barlow syndrome. Circulation. 2003; 108(16):e116-7. DOI: 10.1161/01.CIR.0000092236.67713.04
Chen S, Fagan LF, Nouri S, Donahoe JL. Ventricular dysrhythmias in children with Marfan’s syndrome. Am J Dis Child. 1985; 139(3):273-6. DOI: 10.1001/archpedi.1985.02140050067024
Sisk HE, Zahka KG, Pyeritz RE. The Marfan syndrome in early childhood: analysis of 15 patients diagnosed at less than 4 years of age. Am J Cardiol. 1983; 52(3):353-8. DOI: 10.1016/0002-9149(83)90138-8
Wilcken DE. Genes, gender and geometry and the prolapsing mitral valve. Aust N Z J Med. 1992; 22(5 Suppl):556-61. DOI: 10.1111/j.1445-5994.1992.tb00476.x
Ponikowski P, Voors A, Anker S, Bueno H, Cleland JGF, Coats AJS, et al. Guía ESC 2016 sobre el diagnóstico y tratamiento de la insuficiencia cardíaca aguda y crónica. Rev Esp Cardiol. 2016; 69(12):1167.e1-1167.e85. DOI: 10.1016/j.recesp.2016.10.014
Malev E, Reeva S, Vasina L, Timofeev E, Pshepiy A, Korshunova A, Prokudina M, Zemtsovsky E. Cardiomyopathy in young adults with classic mitral valve prolapse. Cardiol Young. 2014; 24(4):694-701. DOI: 10.1017/S1047951113001042
Rodríguez-González M, Matamala-Morillo MÁ, Segado-Arenas A, Marín-Iglesias Mdel R, Lechuga-Sancho AM. Chest Pain in Children With Suspected Type I Fibrillinopathy: A Case Report. Pediatrics. 2015; 136(4):e1035-8. DOI: 10.1542/peds.2014-2666
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Salutem Scientia Spiritus
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
La Revista Salutem Scientia Spiritus usa la licencia Creative Commons de Atribución – No comercial – Sin derivar: Los textos de la revista son posibles de ser descargados en versión PDF siempre que sea reconocida la autoría y el texto no tenga modificaciones de ningún tipo.
